Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 21,156,000 | 20,993,000 | 22,232,000 | 19,687,000 | 17,534,000 |
| Cost of Goods | 8,671,000 | 8,600,000 | 8,527,000 | 7,351,000 | 6,835,000 |
| Gross Profit | 12,485,000 | 12,393,000 | 13,705,000 | 12,336,000 | 10,699,000 |
| Operating Expenses | 8,467,000 | 8,816,000 | 8,953,000 | 8,140,000 | 7,889,000 |
| Operating Income | 4,018,000 | 3,577,000 | 4,752,000 | 4,196,000 | 2,810,000 |
| Interest Expense | 292,000 | 321,000 | 235,000 | 272,000 | 387,000 |
| Other Income | -190,000 | 228,000 | -230,000 | 0 | 207,000 |
| Pre-tax Income | 3,536,000 | 3,484,000 | 4,287,000 | 3,924,000 | 2,630,000 |
| Income Tax | 751,000 | 650,000 | 948,000 | 859,000 | 637,000 |
| Net Income Continuous | 2,785,000 | 2,834,000 | 3,339,000 | 3,065,000 | 1,994,000 |
| Minority Interests | -9,000 | -10,000 | -14,000 | -10,000 | -7,000 |
| Net Income | $2,777,000 | $2,824,000 | $3,326,000 | $3,055,000 | $1,987,000 |
| EPS Basic Total Ops | 6.39 | 6.49 | 7.65 | 7.03 | 4.57 |
| EPS Basic Continuous Ops | 6.39 | 6.49 | 7.65 | 7.03 | 4.57 |
| EPS Diluted Total Ops | 6.39 | 6.49 | 7.65 | 7.03 | 4.57 |
| EPS Diluted Continuous Ops | 6.39 | 6.49 | 7.65 | 7.03 | 4.57 |
| EBITDA(a) | $5,962,000 | $5,685,000 | $6,552,000 | $5,958,000 | $4,955,000 |